JO
KPRX icon

John Overdeck’s Kiora Pharmaceuticals KPRX Stock Holding History

John Overdeck’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
+88,792
New +$223K ﹤0.01% 4683
2025
Q4 		– Sell
-11,984
Closed -$33.3K – 4255
2025
Q3 		$33.3K Buy
+11,984
New +$32.9K ﹤0.01% 3564
2024
Q2 		– Sell
-1,150
Closed -$7.31K – 3189
2024
Q1 		$7.31K Buy
+1,150
New +$6.43K ﹤0.01% 2965
2021
Q3 		– Sell
-75
Closed -$99K – 4488
2021
Q2 		$99K Sell
75
-72
-49% -$112K ﹤0.01% 3899
2021
Q1 		$263K Buy
+147
New +$320K ﹤0.01% 3433

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

John Overdeck's KPRX Position: Q2 2026 in Review

John Overdeck opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 88,792 shares worth $234K. The stake represents ﹤0.01% of the portfolio and ranks #4683 among its holdings. This is a return to the name: John Overdeck previously reported a position in KPRX as recently as Q3 2025.

John Overdeck first reported a position in KPRX in Q1 2021 and has held it in 5 quarters since. The position peaked at $263K in Q1 2021. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • John Overdeck held 88,792 shares of Kiora Pharmaceuticals worth $234K as of Q2 2026.
  • Kiora Pharmaceuticals was a new John Overdeck position in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4683 holding.
  • John Overdeck first reported a position in Kiora Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
  • John Overdeck's Kiora Pharmaceuticals position peaked at $263K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.